McAdam LLC’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3	Closed	–	–	146
2018 Q3	$0	Hold	3	–	–	﹤0.01%	668
2018 Q2	$0	Buy	+3	New	–	﹤0.01%	662